There was a lower incidence of major and minor criteria, except hearing loss, among individuals with SIX1 variants compared to clinical EYA1 variant cohorts, and the phenotypic features related to DFNA23 or atypical BO syndrome were highlighted in SIX1 variants. This evidence concerns the gene EYA1 and hearing loss disorder.